Cytokinetics (CYTK) Misses Q4 EPS by 24c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $77.74 +2.16%
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q4 EPS of ($1.45), $0.24 worse than the analyst estimate of ($1.21). Revenue for the quarter came in at $1.96 million versus the consensus estimate of $7.45 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
